Abtak Logo

alembic-pharmaceuticals News

Stay updated with the latest alembic-pharmaceuticals news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on alembic-pharmaceuticals topics.

India TV News - Other Politics Business Technology Entertainment - News Image
soure image
26

Nimisha Priya's execution in Yemen, scheduled for today, postponed after Grand Mufti of India and Sh...

New Delhi: The death sentence of Kerala nurse Nimisha Priya, who was sentenced to death in Yemen, has been postponed for the time being. She was to be executed by shooting today, July 16. According to media reports, activist groups and influential religious leaders intervened in the matter, after which the death sentence of Nimisha Priya was postponed. Earlier, many efforts were also made at the diplomatic level to save Nimisha from the death penalty. There is also news that the victim's family ...Read More >

Deccan Chronicle - Technology - News Image
soure image
21
TechnologyJul 16, 2025 01:13 AM

Visakhapatnam, Vijayawada Among Fastest-growing Non-metro Hubs

Vijayawada: LinkedIn, the world's largest professional network, has come up with a 'Cities on the Rise' list, with spotlight on the top 10 cities in India where the job market as well as economic opportunities are steadily growing. As per the list, Visakhapatnam and Vijayawada, in first and third slots, are among the top three fastest-growing non-metro hubs where professional opportunities are accelerating. The following is the list of LinkedIn's Cities on the Rise 2025 for India: 1 Visakhapat ...Read More >

fallback-img
soure image
14
BusinessJul 04, 2025 11:50 AM

Alembic Pharmaceuticals acquires Utility Therapeutics for $12 million to strengthen U.S. footprint -...

Bengaluru: Alembic Pharmaceuticals, Inc., the U.S. subsidiary of Alembic Pharmaceuticals Ltd., has acquired Utility Therapeutics Ltd. ("Utility") in a $12 million deal to strengthen its presence in the U.S. market. Alembic will begin the commercialization of Utility's recently FDA approved product Pivya® (pivmethecillam) for the treatment of uncomplicated urinary tract infections. Pivya® was approved by the FDA in April 2024. Commenting on the acquisition, Mr. Pranav Amin, Managing Director of ...Read More >

LatestLY - Business - News Image
soure image
15
BusinessJul 03, 2025 10:38 AM

Latest News | Alembic Acquires Utility Therapeutics for USD 12 Mn | LatestLY

New Delhi, Jul 3 (PTI) Alembic Pharmaceuticals on Thursday said its US arm has acquired Utility Therapeutics Ltd in a USD 12 million (over Rs 100 crore) deal to strengthen its presence in the American market. The acquisition is being done by Alembic Pharmaceuticals, Inc, the company's US subsidiary, Alembic said in a statement. Also Read | Kolkata Fatafat Result Today: Kolkata FF Result for July 03, 2025 Declared, Check Winning Numbers and Result Chart of Satta Matka-Type Lottery Game. Subseq ...Read More >

fallback-img
soure image
4
BusinessJul 01, 2025 09:34 AM

Alembic Pharmaceuticals Limited announces USFDA Final Approval for Doxorubicin Hydrochloride Liposom...

Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Doxorubicin Hydrochloride Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Doxil Liposome Injection, 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL), of Baxter Health ...Read More >

NewsDrum - Business - News Image
soure image
21
BusinessJun 30, 2025 12:34 PM

Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injection

New Delhi, Jun 30 (PTI) Alembic Pharmaceuticals on Monday said it has received the final approval from the US health regulator for its generic Doxorubicin Hydrochloride Liposome injection in different types of cancer. The approval by the US Food & Drug Administration (USFDA) for the abbreviated new drug application (ANDA) is for Doxorubicin Hydrochloride Liposome injection of strengths 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) single-dose vials, Alembic Pharmaceuticals said in a statement ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.